Session 2: Eligibility & Payer Authorization
19 Jan 2027
Theatre 5
Empowering Patients, Delivering Access (in Partnership with the Emily Whitehead Foundation)
The second-opinion problem and the prior-authorization wall. Presenting the direct-to-patient referral and navigation model that removes the financial friction at the point of eligibility assessment. CAR-T Vision 2030 frames the system-level gap: What would the payer and authorization workflow have to look like to double the treated population by 2030?
Topic
CDMO CRO & Partnering,Cell Therapy ,Clinical Development & Regulatory Strategy,Commercialisation & Market Access,Entrepreneurship & Founders,Gene Therapy,Patient Access Equity & Advocacy,Oncology
Persona
Biotech,Clinicians,Patient Advocates & Organizations,Payers,Pharma,Regulators & Policy Makers,Service Providers (CDMOs CROs & Suppliers),Tools tech & equipment providers